Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Revidox is a dietary supplement (nutraceutical) developed by Claride Pharmaceuticals and distributed in Mexico by Industria Farmacéutica Andrómaco. It is formulated as an antioxidant complex containing Stilvid® (a proprietary grape extract enriched with resveratrol), pomegranate extract (rich in punicalagins), and selenium. The product is designed to combat oxidative stress and cellular aging by neutralizing free radicals and supporting the body's natural antioxidant defenses, such as glutathione peroxidase. It is primarily marketed for general wellness and anti-aging support and is not classified as a pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Revidox.